Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 2
1968 1
1974 2
1977 1
1978 1
1979 1
1980 2
1981 2
1982 2
1983 1
1984 1
1985 3
1986 1
1987 3
1988 6
1989 3
1990 5
1991 1
1992 2
1994 4
1995 5
1996 4
1997 3
1998 7
1999 3
2000 7
2001 6
2002 5
2003 5
2004 5
2005 7
2006 6
2007 8
2008 10
2009 8
2010 18
2011 13
2012 13
2013 15
2014 7
2015 9
2016 18
2017 17
2018 15
2019 11
2020 21
2021 15
2022 14
2023 21
2024 13
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for terui y
Search for Teruo Y instead (1 results)
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Song Y, Tilly H, Rai S, Zhang H, Jin J, Goto H, Terui Y, Shin HJ, Kim WS, Cao J, Feng J, Eom HS, Kim TM, Tsai XC, Gau JP, Koh H, Zhang L, Song Y, Yang Y, Li W, Huang H, Ando K, Sharman JP, Sehn LH, Bu L, Wang X, Jiang Y, Hirata J, Lee C, Zhu J, Izutsu K. Song Y, et al. Among authors: terui y. Blood. 2023 Apr 20;141(16):1971-1981. doi: 10.1182/blood.2022017734. Blood. 2023. PMID: 36626583 Free PMC article. Clinical Trial.
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma.
Narita Y, Nagane M, Mishima K, Terui Y, Arakawa Y, Yonezawa H, Asai K, Fukuhara N, Sugiyama K, Shinojima N, Kitagawa J, Aoi A, Nishikawa R. Narita Y, et al. Among authors: terui y. Neuro Oncol. 2021 Jan 30;23(1):122-133. doi: 10.1093/neuonc/noaa145. Neuro Oncol. 2021. PMID: 32583848 Free PMC article. Clinical Trial.
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F; LYM-3002 investigators. Robak T, et al. Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348538 Clinical Trial.
Special Issue "Polyamines in Aging and Disease".
Uemura T, Terui Y. Uemura T, et al. Among authors: terui y. Int J Mol Sci. 2024 Nov 7;25(22):11960. doi: 10.3390/ijms252211960. Int J Mol Sci. 2024. PMID: 39596032 Free PMC article.
[Cytidine].
Terui Y. Terui Y. Nihon Rinsho. 2015 Feb;73 Suppl 2:159-61. Nihon Rinsho. 2015. PMID: 25831743 Japanese. No abstract available.
[Proteasome inhibitors].
Hatake K, Mishima Y, Terui Y. Hatake K, et al. Among authors: terui y. Gan To Kagaku Ryoho. 2004 Jul;31(7):999-1002. Gan To Kagaku Ryoho. 2004. PMID: 15272575 Review. Japanese.
[CD20].
Terui Y. Terui Y. Nihon Rinsho. 2012 Nov;70 Suppl 8:170-5. Nihon Rinsho. 2012. PMID: 23513833 Japanese. No abstract available.
[Pathogenesis of lymphoma].
Terui Y. Terui Y. Nihon Rinsho. 2014 Mar;72(3):386-9. Nihon Rinsho. 2014. PMID: 24724392 Japanese. No abstract available.
321 results